Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated May 10, 2025, titled "Completion of USFDA inspection in Ambernath facility".
Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated May 10, 2025, titled "Completion of USFDA inspection in Ambernath facility".